TickerFacts.

Alaunos Therapeutics, Inc. (TCRT): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2016-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$165.02M
Year ended 2016-12-31
2009-12-31: -$11.79M2010-12-31: -$24.36M2011-12-31: -$71.13M2012-12-31: -$101.51M2013-12-31: -$56.98M2014-12-31: -$43.04M2015-12-31: -$119.74M2016-12-31: -$165.02M-$165.02M
2009-12-31 EBITDA (USD) 2016-12-31
Period endedEBITDAChange YoYSource filing
2016-12-31-$165.02Mn/m2019-03-05, From 2016-01-01
2015-12-31-$119.74Mn/m2018-03-01, From 2015-01-01
2014-12-31-$43.04Mn/m2017-02-16, From 2014-01-01
2013-12-31-$56.98Mn/m2016-02-24, From 2013-01-01
2012-12-31-$101.51Mn/m2015-02-26, From 2012-01-01
2011-12-31-$71.13Mn/m2014-03-03, From 2011-01-01
2010-12-31-$24.36Mn/m2013-03-18, From 2010-01-01
2009-12-31-$11.79Mn/a2012-02-29, From 2009-01-01